FRES
Price
$1.02
Change
+$0.01 (+0.99%)
Updated
Nov 14 closing price
PXXLF
Price
$0.70
Change
-$0.00 (-0.00%)
Updated
Apr 11 closing price
Ad is loading...

FRES vs PXXLF

Header iconFRES vs PXXLF Comparison
Open Charts FRES vs PXXLFBanner chart's image
Fresh2 Group
Price$1.02
Change+$0.01 (+0.99%)
Volume$2.46K
CapitalizationN/A
Poxel SA
Price$0.70
Change-$0.00 (-0.00%)
Volume$100
CapitalizationN/A
FRES vs PXXLF Comparison Chart
Loading...
View a ticker or compare two or three
VS
FRES vs. PXXLF commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRES is a StrongBuy and PXXLF is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (FRES: $1.02 vs. PXXLF: $0.70)
Brand notoriety: FRES and PXXLF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FRES: 4% vs. PXXLF: 100%
Market capitalization -- FRES: $2.5M vs. PXXLF: $13.84M
FRES [@Biotechnology] is valued at $2.5M. PXXLF’s [@Biotechnology] market capitalization is $13.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FRES’s FA Score shows that 1 FA rating(s) are green whilePXXLF’s FA Score has 1 green FA rating(s).

  • FRES’s FA Score: 1 green, 4 red.
  • PXXLF’s FA Score: 1 green, 4 red.
According to our system of comparison, PXXLF is a better buy in the long-term than FRES.

Price Growth

FRES (@Biotechnology) experienced а -24.44% price change this week, while PXXLF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

FRES is expected to report earnings on May 16, 2023.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
PXXLF($13.8M) has a higher market cap than FRES($2.5M). PXXLF YTD gains are higher at: 16.667 vs. FRES (-88.539).
FRESPXXLFFRES / PXXLF
Capitalization2.5M13.8M18%
EBITDAN/AN/A-
Gain YTD-88.53916.667-531%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
PXXLF: Fundamental Ratings
PXXLF
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

FRES and

Correlation & Price change

A.I.dvisor indicates that over the last year, FRES has been closely correlated with CLNN. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if FRES jumps, then CLNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FRES
1D Price
Change %
FRES100%
+0.99%
CLNN - FRES
81%
Closely correlated
-2.70%
RIGL - FRES
78%
Closely correlated
+0.18%
DARE - FRES
77%
Closely correlated
-7.04%
HOOK - FRES
76%
Closely correlated
-8.19%
AZTR - FRES
73%
Closely correlated
-7.90%
More

PXXLF and

Correlation & Price change

A.I.dvisor tells us that PXXLF and SEOVF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PXXLF and SEOVF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PXXLF
1D Price
Change %
PXXLF100%
N/A
SEOVF - PXXLF
29%
Poorly correlated
+4.84%
RAPT - PXXLF
28%
Poorly correlated
-18.47%
CDTX - PXXLF
24%
Poorly correlated
+4.17%
CLVLF - PXXLF
22%
Poorly correlated
-7.75%
FRES - PXXLF
21%
Poorly correlated
+0.99%
More